ITC CONTOUR EMBOLI, MODIFICATION— 510(k) K914866

Name: FDA 510(k) clearance K914866
Creator: U.S. Food and Drug Administration
Published: 1993-11-09

Substantially Equivalent

Interventional Therapeutics Corp.

FDA 510(k) clearance K914866 for ITC CONTOUR EMBOLI, MODIFICATION, Substantially Equivalent on 1993-11-09. Applicant: Interventional Therapeutics Corp.. Device class: 2.

Clearance details

Applicant: Interventional Therapeutics Corp.
Product code: Code HCG
Device class: Class 2
Regulation: 21 CFR 882.5950
Advisory panel: Neurology
Date received: 1991-10-29
Decision date: 1993-11-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: South San Francisco, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code HCG

view all

K262419 — MICRUSFRAME (19+ models)2026-08-14
K261772 — Target Xtra Detachable Coil2026-06-24
K260351 — Numen Helia Coil Embolization System; NumenFR Detachment System2026-05-20
K254221 — Optima Coil System (OptiOne Coil System)2026-01-27
K252694 — Target Detachable Coil2025-12-11

More clearances from Interventional Therapeutics Corp.

view all

K960832 — OCCLUSION BALLOON CATHETER1996-05-29
K950398 — CATHETER, BALLOON TYPE1995-10-05
K945588 — DISPOSABLE 1CC SYRINGE WITH LUER LOCK1995-02-10
K944354 — CONTOUR EMBOLI1994-12-13
K930456 — INTHERM SINGLE-STICK RADIALLY EXPANDING DILATOR1993-11-17

Adverse events under product code HCG

product code HCG

Death: 50
Injury: 801
Malfunction: 5,625
Total: 6,476

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.